SUZHOU HIGHFINE BIOTECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.42 CNY | +1.00% |
|
+24.50% | -9.32% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 672M 92.96M | Sales 2025 * | 888M 123M | Capitalization | 5.88B 814M |
|---|---|---|---|---|---|
| Net income 2024 * | 194M 26.85M | Net income 2025 * | 257M 35.57M | EV / Sales 2024 * | 8.75 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.62 x |
| P/E ratio 2024 * |
30.2
x | P/E ratio 2025 * |
22.9
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.27% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.00% | ||
| 1 week | +24.50% | ||
| Current month | +24.50% | ||
| 1 month | +22.21% | ||
| 3 months | +29.33% | ||
| 6 months | -27.65% | ||
| Current year | -9.32% |
1 week
44.60
58.22
1 month
36.7158.22
Current year
36.5160.88
1 year
36.51118.88
3 years
36.51118.88
5 years
36.51118.88
10 years
36.51118.88
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Zhu
CEO | Chief Executive Officer | 53 | 03-12-01 |
Xiao Yan Wang
DFI | Director of Finance/CFO | 44 | 04-01-31 |
Hao Yi Sun
CHM | Chairman | 46 | 11-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qing Wang
BRD | Director/Board Member | 58 | 21-05-31 |
Yong Zhu
CEO | Chief Executive Officer | 53 | 03-12-01 |
Jie Xu
BRD | Director/Board Member | 45 | 04-10-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 54.42 | +1.00% | 5,265,060 |
| 24-05-09 | 53.88 | -1.14% | 6,595,095 |
| 24-05-08 | 54.5 | +3.89% | 7,223,424 |
| 24-05-07 | 52.46 | +0.02% | 9,282,508 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotes
Suzhou Highfine Biotech Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of Peptide synthesis reagents. The Company's main products include Peptide synthesis reagents such as condensation reagents, protection reagents and chiral racemic inhibition reagents, general-purpose molecular blocks and protein reagents.
Sector
Commodity Chemicals
Calendar
2024-08-15
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
54.42
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.32% | 813M | |
| +5.97% | 105B | |
| -4.43% | 63.99B | |
| +51.90% | 42.95B | |
| +17.44% | 39.2B | |
| +6.62% | 33.01B | |
| +13.00% | 20.33B | |
| +15.64% | 17.29B | |
| +22.55% | 15.72B | |
| +7.34% | 14.72B |
- Stock Market
- Equities
- 301393 Stock